Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/07/2007EP1851193A1 Hiv protease inhibitors
11/07/2007EP1851192A1 Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride
11/07/2007EP1851191A1 Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds
11/07/2007EP1850880A2 Aptamer therapeutics useful in the treatment of complement-related disorders
11/07/2007EP1850879A1 Method of genotypically modifying cells by administration of rna
11/07/2007EP1850858A2 Polyethylene oxide polymers including anti-inflammatory glycodendrons
11/07/2007EP1850857A2 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
11/07/2007EP1850856A1 Dosage and method for attaining beneficial levels of vitamin d3
11/07/2007EP1850854A1 Room temperature stable aqueous liquid pharmaceutical composition
11/07/2007EP1850853A2 Pharmacokinetically improved compounds
11/07/2007EP1850852A2 Use of sildenafil, vardenafil and other 5-phosphodiesterase inhibitors to enhance permeability of the abnormal blood-brain barrier
11/07/2007EP1850851A2 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines
11/07/2007EP1850850A2 Compositions and methods for targeted delivery of immune response modifiers
11/07/2007EP1850849A2 Method of preferentially inducing the biosynthesis of interferon
11/07/2007EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof
11/07/2007EP1850847A2 Inhibitors of checkpoint kinases
11/07/2007EP1850846A1 Composition comprising a jnk inhibitor and cyclosporin
11/07/2007EP1850845A2 Formulations and dosing regimen for ppar-alpha modulators
11/07/2007EP1850844A2 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
11/07/2007EP1850843A2 Inhibitors of akt activity
11/07/2007EP1850842A1 Pharmaceutical compositions comprising nebivolol and a hydrophilic polymer
11/07/2007EP1850841A1 Methods for qt interval control
11/07/2007EP1850840A2 Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
11/07/2007EP1850839A2 Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors
11/07/2007EP1850838A2 Inhibition or treatment of dyskinesia
11/07/2007EP1850837A1 Use of morpholino compounds for the prevention of bacterial contamination
11/07/2007EP1850835A1 Oral pharmaceutical for of losartan
11/07/2007EP1850833A2 Formulations of substituted benzoxazoles
11/07/2007EP1850831A2 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
11/07/2007EP1850829A2 Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
11/07/2007EP1850827A2 Composition for treating and preventing periodontal disease and method of use
11/07/2007EP1850670A1 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
11/07/2007EP1850667A2 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
11/07/2007EP1850663A2 Use of minoxidil sulfate as an anti-tumor drug
11/07/2007EP1804795A4 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
11/07/2007EP1790357A4 Perorally administrable antimicrobial composition
11/07/2007EP1773814B1 Substituted oxindol derivatives and medicaments containing the same
11/07/2007EP1732953B1 Hydroxyethyl starch
11/07/2007EP1664033B1 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
11/07/2007EP1624753A4 Purinergic modulation of smell
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1576961B1 Use of silymarin and carbopol as a regenerator of pancreatic tissue and cells with endocrine secretion damaged by diabetes mellitus
11/07/2007EP1572203B1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
11/07/2007EP1553831A4 Process for screening fungitoxic compounds
11/07/2007EP1543008B1 Imidazopyrazines as cyclin dependent kinase inhibitors
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007EP1534311B1 Method for identifying modulators of ion channels
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1435923A4 Methods and apparatus for improved administration of analgesics
11/07/2007EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1374901B9 Graft rejection suppressors
11/07/2007EP1362127B1 Serpin drugs for treatment of hiv infection and method of use thereof
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1276473B1 Pharmaceutical formulations for dry powder inhalers
11/07/2007EP1263770B1 6-oxygenated steroidal estrogens with aromatic a and b rings
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007EP1165523B1 Neurotrophic substituted pyrimidines
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007EP0915094B1 Morphinane derivatives and medicinal use thereof
11/07/2007EP0833624B1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
11/07/2007EP0814785B1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
11/07/2007CN101068926A Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
11/07/2007CN101068827A Polymorphs of sarsasapogenin
11/07/2007CN101068826A Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/07/2007CN101068825A 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
11/07/2007CN101068824A Ester linked macrolides useful for the treatment of microbial infections
11/07/2007CN101068823A Tetrahydropyrane derivatives for use as antidiabetics
11/07/2007CN101068820A Non-hygroscopic and powdery amorphous pimecrolimus
11/07/2007CN101068818A Methods of preparing pimecrolimus
11/07/2007CN101068817A Novel thienopyridinepyrimidine derivatives
11/07/2007CN101068816A Novel thienopyridinepyrimidine derivatives
11/07/2007CN101068815A Lactam compounds useful as protein kinase inhibitors
11/07/2007CN101068812A Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
11/07/2007CN101068810A Carbostyril compound
11/07/2007CN101068809A Substituted indole compounds and their use as 5-ht6 receptor modulators
11/07/2007CN101068806A (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
11/07/2007CN101068805A Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
11/07/2007CN101068801A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101068797A Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
11/07/2007CN101068793A Potassium salt of an HIV integrase inhibitor
11/07/2007CN101068792A Amorphous and polymorphic forms of telmisartan sodium
11/07/2007CN101068788A Quinoline as allosteric enhancers of the gaba-b receptors
11/07/2007CN101068786A 3-substituted pyridine derivatives as h3 antagonists
11/07/2007CN101068785A Hydroxybenzoate salts of metanicotine compounds
11/07/2007CN101068784A Hydroxybenzoate salts of metanicotine compounds
11/07/2007CN101068781A Compounds for alzheimer's disease
11/07/2007CN101068779A 9,10-secopregnane derivative and medicine
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN101068773A Melanin concentrating hormone antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068769A Arakyl amine vanadium (v) salt for treating or/and preventing diabetic
11/07/2007CN101068764A 雌激素受体调节剂 Estrogen receptor modulators
11/07/2007CN101068597A Fumarate of 4-((4-(4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile
11/07/2007CN101068596A Ecteinascidin compounds as anti-inflammatory agents
11/07/2007CN101068595A Cgrp受体拮抗剂 Cgrp receptor antagonists
1 ... 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 ... 7860